MET and pancreatic ductal adenocarcinoma: Furthermore, HGF-c-MET signaling also leads to activation of the PI3K/AKT pathway [69] and AKT1 has been identified as a direct target of hsa-miR-637 in pancreatic ductal adenocarcinoma cells [70].